T cell responses in the central nervous system

Nature Reviews Immunology

Volumn 17, Issue 3, 2017, Pages 179-194

  Korn, Thomas ^a,b   Kallies, Axel ^c,d  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Technische Universität München Munich Cluster for Systems Neurology   (Germany)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PLASTICITY; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM INFECTION; DENDRITIC CELL; EFFECTOR CELL; HUMAN; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION; ANIMAL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION;

ANIMALS; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM; HUMANS; LYMPHOCYTE ACTIVATION; VIRUS DISEASES;

EID: 85010986744     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri.2016.144     Document Type: Review

References (255)

1. Williams, K. A., Hart, D. N., Fabre, J. W., Morris, P. J. Distribution and quantitation of HLA-ABC and DR (Ia) antigens on human kidney and other tissues. Transplantation 29, 274-279 (1980
2. Ransohoff, R. M., Engelhardt, B. The anatomical and cellular basis of immune surveillance in the central nervous system. Nat. Rev. Immunol. 12, 623-635 (2012
3. Engelhardt, B., Sorokin, L. The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction. Semin. Immunopathol. 31, 497-511 (2009
4. Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., Begley, D. J. Structure and function of the blood-brain barrier. Neurobiol. Dis. 37, 13-25 (2010
5. Zhao, Z., Nelson, A. R., Betsholtz, C., Zlokovic, B. V. Establishment and dysfunction of the blood-brain barrier. Cell 163, 1064-1078 (2015
6. Bechmann, I., Galea, I., Perry, V. H. What is the blood-brain barrier (not) Trends Immunol. 28, 5-11 (2007
7. Galea, I., Bechmann, I., Perry, V. H. What is immune privilege (not) Trends Immunol. 28, 12-18 (2007
8. Russo, M. V., McGavern, D. B. Immune surveillance of the CNS following infection and injury. Trends Immunol. 36, 637-650 (2015).
9. Wakim, L. M., Woodward-Davis, A., Bevan, M. J. Memory T cells persisting within the brain after local infection show functional adaptations to their tissue of residence. Proc. Natl Acad. Sci. USA 107, 17872-17879 (2010
10. Steinbach, K., et al. Brain-resident memory T cells represent an autonomous cytotoxic barrier to viral infection. J. Exp. Med. 213, 1571-1587 (2016
11. Iijima, N., Iwasaki, A. T cell memory. A local macrophage chemokine network sustains protective tissue-resident memory CD4 T cells. Science 346, 93-98 (2014
12. Sathaliyawala, T., et al. Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets. Immunity 38, 187-197 (2013
13. Teijaro, J. R., et al. Cutting edge: tissue-retentive lung memory CD4 T cells mediate optimal protection to respiratory virus infection. J. Immunol. 187, 5510-5514 (2011
14. Lueg, G., et al. Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer's disease. Neurobiol. Aging 36, 81-89 (2015
15. Saunders, J. A. H., et al. CD4+ regulatory and effector/memory T cell subsets profile motor dysfunction in Parkinson's disease. J. Neuroimmune Pharmacol. 7, 927-938 (2012
16. Raj, T., et al. Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes. Science 344, 519-523 (2014
17. Lang, H. L. E., et al. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat. Immunol. 3, 940-943 (2002
18. Mora, J. R., et al. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 424, 88-93 (2003
19. Hemmer, B., Kerschensteiner, M., Korn, T. Role of the innate and adaptive immune responses in the course of multiple sclerosis. Lancet Neurol. 14, 406-419 (2015
20. Beecham, A. H., et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat. Genet. 45, 1353-1360 (2013
21. Rouvire, H. Anatomy of the Human Lymphatic System (Edwards Bros. Inc., 1938
22. Prineas, J. W. Multiple sclerosis: presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord. Science 203, 1123-1125 (1979
23. Banerji, S., et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 144, 789-801 (1999
24. Head, J. R., Griffin, W. S. Functional capacity of solid tissue transplants in the brain: evidence for immunological privilege. Proc. R. Soc. Lond. B Biol. Sci. 224, 375-387 (1985
25. Barker, C. F., Billingham, R. E. The role of afferent lymphatics in the rejection of skin homografts. J. Exp. Med. 128, 197-221 (1968
26. Locatelli, G., et al. Primary oligodendrocyte death does not elicit anti-CNS immunity. Nat. Neurosci. 15, 543-550 (2012
27. Traka, M., Podojil, J. R., McCarthy, D. P., Miller, S. D., Popko, B. Oligodendrocyte death results in immune-mediated CNS demyelination. Nat. Neurosci. 19, 65-74 (2016
28. Louveau, A., et al. Structural and functional features of central nervous system lymphatic vessels. Nature 523, 337-341 (2015
29. Louveau, A., Da Mesquita, S., Kipnis, J. Lymphatics in neurological disorders: a neuro-lympho-vascular component of multiple sclerosis and Alzheimer's disease Neuron 91, 957-973 (2016
30. Xie, L., et al. Sleep drives metabolite clearance from the adult brain. Science 342, 373-377 (2013
31. Raper, D., Louveau, A., Kipnis, J. How do meningeal lymphatic vessels drain the CNS Trends Neurosci. 39, 581-586 (2016
32. Hladky, S. B., Barrand, M. A. Mechanisms of fluid movement into, through and out of the brain: evaluation of the evidence. Fluids Barriers CNS 11, 26 (2014
33. Bettelli, E., et al. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197, 1073-1081 (2003
34. Krishnamoorthy, G., et al. Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis. Nat. Med. 15, 626-632 (2009
35. Na, S.-Y., et al. Oligodendrocytes enforce immune tolerance of the uninfected brain by purging the peripheral repertoire of autoreactive CD8+ T cells. Immunity 37, 134-146 (2012
36. Fletcher, A. L., Malhotra, D., Turley, S. J. Lymph node stroma broaden the peripheral tolerance paradigm. Trends Immunol. 32, 12-18 (2011
37. Rouhani, S. J., et al. Roles of lymphatic endothelial cells expressing peripheral tissue antigens in CD4 T-cell tolerance induction. Nat. Commun. 6, 6771 (2015
38. Rosenberger, K., et al. Intrathecal heat shock protein 60 mediates neurodegeneration and demyelination in the CNS through a TLR4-and MyD88-dependent pathway. Mol. Neurodegener. 10, 5 (2015
39. Brown, D. A., Sawchenko, P. E. Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis. J. Comp. Neurol. 502, 236-260 (2007
40. Reboldi, A., et al. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 10, 514-523 (2009
41. Bartholomus, I., et al. Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature 462, 94-98 (2009
42. Schlger, C., et al. Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid. Nature 530, 349-353 (2016
43. Kiviskk, P., et al. Localizing central nervous system immune surveillance: meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis. Ann. Neurol. 65, 457-469 (2009
44. Vajkoczy, P., Laschinger, M., Engelhardt, B. 4-integrin-VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels. J. Clin. Invest. 108, 557-565 (2001
45. Prodinger, C., et al. CD11c-expressing cells reside in the juxtavascular parenchyma and extend processes into the glia limitans of the mouse nervous system. Acta Neuropathol. 121, 445-458 (2011
46. Bulloch, K., et al. CD11c/EYFP transgene illuminates a discrete network of dendritic cells within the embryonic, neonatal, adult, and injured mouse brain. J. Comp. Neurol. 508, 687-710 (2008
47. Bailey, S. L., Schreiner, B., McMahon, E. J., Miller, S. D. CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ TH-17 cells in relapsing EAE. Nat. Immunol. 8, 172-180 (2007
48. Pinschewer, D. D., et al. T cells can mediate viral clearance from ependyma but not from brain parenchyma in a major histocompatibility class I-and perforin-independent manner. Brain 133, 1054-1066 (2010
49. Hickey, W. F., Kimura, H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239, 290-292 (1988
50. Greter, M., et al. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 11, 328-334 (2005
51. Anandasabapathy, N., et al. Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain. J. Exp. Med. 208, 1695-1705 (2011
52. Ifergan, I., et al. The blood-brain barrier induces differentiation of migrating monocytes into Th17-polarizing dendritic cells. Brain 131, 785-799 (2008
53. Croxford, A. L., Spath, S., Becher, B. GM-CSF in neuroinflammation: licensing myeloid cells for tissue damage. Trends Immunol. 36, 651-662 (2015
54. Ji, Q., Castelli, L., Goverman, J. M. MHC class I-restricted myelin epitopes are cross-presented by Tip-DCs that promote determinant spreading to CD8+ T cells. Nat. Immunol. 14, 254-261 (2013
55. Goldmann, T., et al. Origin, fate and dynamics of macrophages at central nervous system interfaces. Nat. Immunol. 17, 797-805 (2016
56. Jordan, F. L., Thomas, W. E. Brain macrophages: questions of origin and interrelationship. Brain Res. 472, 165-178 (1988
57. Flach, A.-C., et al. Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease. Proc. Natl Acad. Sci. USA 113, 3323-3328 (2016
58. Lanzavecchia, A. Antigen-specific interaction between T and B cells. Nature 314, 537-539 (1985
59. Molnarfi, N., et al. MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies. J. Exp. Med. 210, 2921-2937 (2013
60. Kowarik, M. C., et al. Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS. Neurology 76, 1214-1221 (2011
61. Pierson, E. R., Stromnes, I. M., Goverman, J. M. B cells promote induction of experimental autoimmune encephalomyelitis by facilitating reactivation of T cells in the central nervous system. J. Immunol. 192, 929-939 (2014
62. Magliozzi, R., et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 130, 1089-1104 (2007
63. Howell, O. W., et al. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain 134, 2755-2771 (2011
64. Pikor, N. B., et al. Integration of Th17-and lymphotoxin-derived signals initiates meningeal-resident stromal cell remodeling to propagate neuroinflammation. Immunity 43, 1160-1173 (2015
65. Mitsdoerffer, M., Peters, A. Tertiary lymphoid organs in central nervous system autoimmunity. Front. Immunol. 7, 451 (2016
66. Verma, S., Kumar, M., Gurjav, U., Lum, S., Nerurkar, V. R. Reversal of West Nile virus-induced blood-brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitor. Virology 397, 130-138 (2010
67. McMinn, P. C. The molecular basis of virulence of the encephalitogenic flaviviruses. J. Gen. Virol. 78, 2711-2722 (1997
68. Alexaki, A., Wigdahl, B. HIV-1 infection of bone marrow hematopoietic progenitor cells and their role in trafficking and viral dissemination. PLoS Pathog. 4, e1000215 (2008
69. Chapagain, M. L., Nerurkar, V. R. Human polyomavirus JC (JCV) infection of human B lymphocytes: a possible mechanism for JCV transmigration across the blood-brain barrier. J. Infect. Dis. 202, 184-191 (2010
70. Salinas, S., Schiavo, G., Kremer, E. J. A hitchhiker's guide to the nervous system: the complex journey of viruses and toxins. Nat. Rev. Microbiol. 8, 645-655 (2010
71. Iannacone, M., et al. Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus. Nature 465, 1079-1083 (2010
72. Rothhammer, V., et al. 4-integrins control viral meningoencephalitis through differential recruitment of T helper cell subsets. Acta Neuropathol. Commun. 2, 27 (2014
73. Marten, N. W., Stohlman, S. A., Zhou, J., Bergmann, C. C. Kinetics of virus-specific CD8+-T-cell expansion and trafficking following central nervous system infection. J. Virol. 77, 2775-2778 (2003
74. Irani, D. N., Griffin, D. E. Regulation of lymphocyte homing into the brain during viral encephalitis at various stages of infection. J. Immunol. 156, 3850-3857 (1996
75. Soilu-Hänninen, M., Roÿttä, M., Salmi, A. A., Salonen, R. Semliki Forest virus infection leads to increased expression of adhesion molecules on splenic T-cells and on brain vascular endothelium. J. Neurovirol. 3, 350-360 (1997
76. Curis, C., et al. Human T-lymphotropic virus type 1-induced overexpression of activated leukocyte cell adhesion molecule (ALCAM) facilitates trafficking of infected lymphocytes through the blood-brain barrier. J. Virol. 90, 7303-7312 (2016
77. Cayrol, R., et al. Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nat. Immunol. 9, 137-145 (2008
78. Kawakami, N., Flügel, A. Knocking at the brain's door: intravital two-photon imaging of autoreactive T cell interactions with CNS structures. Semin. Immunopathol. 32, 275-287 (2010
79. Korn, T., Mitsdoerffer, M., Kuchroo, V. K. Immunological basis for the development of tissue inflammation and organ-specific autoimmunity in animal models of multiple sclerosis. Results Probl. Cell Differ. 51, 43-74 (2010
80. McCandless, E. E., Zhang, B., Diamond, M. S., Klein, R. S. CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis. Proc. Natl Acad. Sci. USA 105, 11270-11275 (2008
81. Cruz-Orengo, L., et al. CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity. J. Exp. Med. 208, 327-339 (2011
82. Glass, W. G., et al. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J. Exp. Med. 202, 1087-1098 (2005
83. Glass, W. G., et al. CCR5 deficiency increases risk of symptomatic West Nile virus infection. J. Exp. Med. 203, 35-40 (2006
84. Tran, E. H., Kuziel, W. A., Owens, T. Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1 or its CCR5 receptor. Eur. J. Immunol. 30, 1410-1415 (2000
85. Zhang, B., Chan, Y. K., Lu, B., Diamond, M. S., Klein, R. S. CXCR3 mediates region-specific antiviral T cell trafficking within the central nervous system during West Nile virus encephalitis. J. Immunol. 180, 2641-2649 (2008
86. Dufour, J. H., et al. IFN-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J. Immunol. 168, 3195-3204 (2002
87. Müller, M., et al. CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system. J. Immunol. 179, 2774-2786 (2007
88. Lord, G. M., et al. T-Bet is required for optimal proinflammatory CD4+ T-cell trafficking. Blood 106, 3432-3439 (2005
89. Nguyen, K. B., et al. Critical role for STAT4 activation by type 1 interferons in the interferon-response to viral infection. Science 297, 2063-2066 (2002
90. Carter, L. L., Murphy, K. M. Lineage-specific requirement for signal transducer and activator of transcription (Stat)4 in interferon production from CD4+ versus CD8+ T cells. J. Exp. Med. 189, 1355-1360 (1999
91. Hou, W., Kang, H. S., Kim, B. S. Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection. J. Exp. Med. 206, 313-328 (2009
92. Berer, K., Krishnamoorthy, G. Microbial view of central nervous system autoimmunity. FEBS Lett. 588, 4207-4213 (2014
93. Ochoa-Repáraz, J., Kasper, L. H. Gut microbiome and the risk factors in central nervous system autoimmunity. FEBS Lett. 588, 4214-4222 (2014
94. Hall, J. A., et al. Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity 29, 637-649 (2008
95. Berer, K., et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479, 538-541 (2011
96. Haghikia, A., et al. Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine. Immunity 43, 817-829 (2015
97. Wang, S., et al. MyD88 adaptor-dependent microbial sensing by regulatory T cells promotes mucosal tolerance and enforces commensalism. Immunity 43, 289-303 (2015
98. Esser, C., Rannug, A., Stockinger, B. The aryl hydrocarbon receptor in immunity. Trends Immunol. 30, 447-454 (2009
99. Henao-Mejia, J., et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482, 179-185 (2012
100. Erny, D., et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci. 18, 965-977 (2015
101. Rothhammer, V., et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat. Med. 22, 586-597 (2016
102. Quan, N., Whiteside, M., Herkenham, M. Time course and localization patterns of interleukin-1 messenger RNA expression in brain and pituitary after peripheral administration of lipopolysaccharide. Neuroscience 83, 281-293 (1998
103. Yang, Y., et al. Focused specificity of intestinal TH17 cells towards commensal bacterial antigens. Nature 510, 152-156 (2014
104. Teng, F., et al. Gut microbiota drive autoimmune arthritis by promoting differentiation and migration of Peyer's patch T follicular helper cells. Immunity 44, 875-888 (2016
105. Kadowaki, A., et al. Gut environment-induced intraepithelial autoreactive CD4+ T cells suppress central nervous system autoimmunity via LAG-3. Nat. Commun. 7, 11639 (2016
106. McMahon, E. J., Bailey, S. L., Castenada, C. V., Waldner, H., Miller, S. D. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 11, 335-339 (2005
107. Hickey, W. F., Hsu, B. L., Kimura, H. T-Lymphocyte entry into the central nervous system. J. Neurosci. Res. 28, 254-260 (1991
108. Brabb, T., et al. In situ tolerance within the central nervous system as a mechanism for preventing autoimmunity. J. Exp. Med. 192, 871-880 (2000
109. Langrish, C. L., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, 233-240 (2005
110. Kroenke, M. A., Carlson, T. J., Andjelkovic, A. V., Segal, B. M. IL-12-and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J. Exp. Med. 205, 1535-1541 2008
111. Jäger, A., Dardalhon, V., Sobel, R. A., Bettelli, E., Kuchroo, V. K. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 183, 7169-7177 (2009
112. Rothhammer, V., et al. Th17 lymphocytes traffic to the central nervous system independently of 4 integrin expression during EAE. J. Exp. Med. 208, 2465-2476 (2011
113. Stromnes, I. M., Cerretti, L. M., Liggitt, D., Harris, R. A., Goverman, J. M. Differential regulation of central nervous system autoimmunity by TH1 and TH17 cells. Nat. Med. 14, 337-342 (2008
114. Schneider-Hohendorf, T., et al. VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells. J. Exp. Med. 211, 1833-1846 (2014
115. Larochelle, C., et al. Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system. Brain 135, 2906-2924 (2012
116. Du, F., et al. Inflammatory Th17 cells express integrin v3 for pathogenic function. Cell Rep. 16, 1339-1351 (2016
117. Kara, E. E., et al. CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells. Nat. Commun. 6, 8644 (2015
118. Hirota, K., et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 12, 255-263 (2011
119. Kurschus, F. C., et al. Genetic proof for the transient nature of the Th17 phenotype. Eur. J. Immunol. 40, 3336-3346 (2010
120. Codarri, L., et al. RORt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12, 560-567 (2011
121. El-Behi, M., et al. The encephalitogenicity of TH17 cells is dependent on IL-1-and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 12, 568-575 (2011
122. McQualter, J. L., et al. Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J. Exp. Med. 194, 873-882 (2001
123. Heinemann, C., et al. IL-27 and IL-12 oppose pro-inflammatory IL-23 in CD4+ T cells by inducing Blimp1. Nat. Commun. 5, 3770 (2014
124. Grifka-Walk, H. M., Giles, D. A., Segal, B. M. IL-12-polarized Th1 cells produce GM-CSF and induce EAE independent of IL-23. Eur. J. Immunol. 45, 2780-2786 (2015
125. Sheng, W., et al. STAT5 programs a distinct subset of GM-CSF-producing T helper cells that is essential for autoimmune neuroinflammation. Cell Res. 24, 1387-1402 (2014
126. Herndler-Brandstetter, D., Flavell, R. A. Producing GM-CSF: a unique T helper subset Cell Res. 24, 1379-1380 (2014
127. Cua, D. J., et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744-748 (2003
128. Awasthi, A., et al. Cutting edge: IL-23 receptor GFP reporter mice reveal distinct populations of IL-17-producing cells. J. Immunol. 182, 5904-5908 (2009
129. Gaublomme, J. T., et al. Single-cell genomics unveils critical regulators of Th17 cell pathogenicity. Cell 163, 1400-1412 (2015
130. Sherlock, J. P., et al. IL-23 induces spondyloarthropathy by acting on ROR-t+ CD3+CD4-CD8-entheseal resident T cells. Nat. Med. 18, 1069-1076 (2012
131. Reinhardt, A., et al. Interleukin-23-dependent/T cells produce interleukin-17 and accumulate in the enthesis, aortic valve, and ciliary body in mice. Arthritis Rheumatol. 68, 2476-2486 (2016
132. Ciofani, M., et al. A validated regulatory network for Th17 cell specification. Cell 151, 289-303 (2012
133. Teh, P. P., Vasanthakumar, A., Kallies, A. Development and function of effector regulatory T cells. Prog. Mol. Biol. Transl Sci. 136, 155-174 (2015
134. Panduro, M., Benoist, C., Mathis, D. Tissue Tregs. Annu. Rev. Immunol. 34, 609-633 (2016
135. Wu, Y., et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126, 375-387 (2006
136. Rudra, D., et al. Transcription factor Foxp3 and its protein partners form a complex regulatory network. Nat. Immunol. 13, 1010-1019 (2012
137. Chen, Z., et al. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc. Natl Acad. Sci. USA 103, 8137-8142 (2006
138. Gagliani, N., et al. Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature 523, 221-225 (2015
139. Kebir, H., et al. Preferential recruitment of interferon-expressing TH17 cells in multiple sclerosis. Ann. Neurol. 66, 390-402 (2009
140. Wang, Y., et al. The transcription factors T-bet and Runx are required for the ontogeny of pathogenic interferon-producing T helper 17 cells. Immunity 40, 355-366 (2014
141. Krausgruber, T., et al. T-Bet is a key modulator of IL-23-driven pathogenic CD4+ T cell responses in the intestine. Nat. Commun. 7, 11627 (2016
142. Wang, H., et al. Negative regulation of Hif1a expression and TH17 differentiation by the hypoxia-regulated microRNA miR-210. Nat. Immunol. 15, 393-401 (2014
143. Liu, S.-Q., Jiang, S., Li, C., Zhang, B., Li, Q.-J. miR-17-92 cluster targets phosphatase and tensin homology and ikaros family zinc finger 4 to promote TH17-mediated inflammation. J. Biol. Chem. 289, 12446-12456 (2014
144. Ichiyama, K., et al. The microRNA-183-96-182 cluster promotes T helper 17 cell pathogenicity by negatively regulating transcription factor Foxo1 expression. Immunity 44, 1284-1298 (2016
145. Lainffi, A., et al. Foxo1 is a T cell-intrinsic inhibitor of the RORt-Th17 program. J. Immunol. 195, 1791-1803 (2015
146. Wu, C., et al. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 496, 513-517 (2013
147. Jeltsch, K. M., et al. Cleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote TH17 differentiation. Nat. Immunol. 15, 1079-1089 (2014
148. Jankovic, D., Kugler, D. G., Sher, A. IL-10 production by CD4+ effector T cells: a mechanism for self-regulation. Mucosal Immunol. 3, 239-246 (2010
149. Anderson, C. F., Oukka, M., Kuchroo, V. K., Sacks, D. CD4+CD25-Foxp3-Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J. Exp. Med. 204, 285-297 (2007
150. Jankovic, D., et al. Conventional T-bet+Foxp3-Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J. Exp. Med. 204, 273-283 (2007
151. Neumann, C., et al. Role of Blimp-1 in programing Th effector cells into IL-10 producers. J. Exp. Med. 211, 1807-1819 (2014
152. Darrah, P. A., et al. IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform. J. Exp. Med. 207, 1421-1433 (2010
153. Gabrysov-, L., et al. Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells. J. Exp. Med. 206, 1755-1767 (2009
154. Hinger, B., Lozza, L., Steckel, B., Geginat, J. Identification and characterization of IL-10/IFN-producing effector-like T cells with regulatory function in human blood. J. Exp. Med. 206, 1009-1017 (2009
155. Gagliani, N., et al. Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat. Med. 19, 739-746 (2013
156. Cretney, E., et al. The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nat. Immunol. 12, 304-311 (2011
157. Montes de Oca, M., et al. Blimp-1-dependent IL-10 production by Tr1 cells regulates TNF-mediated tissue pathology. PLoS Pathog. 12, e1005398 (2016
158. Lin, M.-H., et al. B lymphocyte-induced maturation protein 1 (BLIMP-1) attenuates autoimmune diabetes in NOD mice by suppressing Th1 and Th17 cells. Diabetologia 56, 136-146 (2013
159. Lin, M.-H., et al. T cell-specific BLIMP-1 deficiency exacerbates experimental autoimmune encephalomyelitis in nonobese diabetic mice by increasing Th1 and Th17 cells. Clin. Immunol. 151, 101-113 (2014
160. Vasanthakumar, A., Kallies, A. IL-27 paves different roads to Tr1. Eur. J. Immunol. 43, 882-885 (2013
161. Jain, R., et al. Interleukin-23-induced transcription factor Blimp-1 promotes pathogenicity of T helper 17 cells. Immunity 44, 131-142 (2016
162. Kallies, A., et al. Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance. Nat. Immunol. 7, 466-474 (2006
163. Meininger, I., et al. Alternative splicing of MALT1 controls signalling and activation of CD4+ T cells. Nat. Commun. 7, 11292 (2016
164. Brtle, A., et al. The NF-B regulator MALT1 determines the encephalitogenic potential of Th17 cells. J. Clin. Invest. 122, 4698-4709 (2012
165. Bornancin, F., et al. Deficiency of MALT1 paracaspase activity results in unbalanced regulatory and effector T and B cell responses leading to multiorgan inflammation. J. Immunol. 194, 3723-3734 (2015
166. Wang, C., et al. CD5L/AIM regulates lipid biosynthesis and restrains Th17 cell pathogenicity. Cell 163, 1413-1427 (2015
167. Herz, J., Johnson, K. R., McGavern, D. B. Therapeutic antiviral T cells noncytopathically clear persistently infected microglia after conversion into antigen-presenting cells. J. Exp. Med. 212, 1153-1169 (2015
168. Ki, D., Ledermann, B., Bki, K., Zinkernagel, R. M., Hengartner, H. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14, 207-232 (1996
169. Guidotti, L. G., Chisari, F. V. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19, 65-91 2001
170. Babbe, H., et al. Clonal expansions of CD8+ T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 192, 393-404 (2000
171. Huseby, E. S., et al. A pathogenic role for myelin-specific CD8+ T cells in a model for multiple sclerosis. J. Exp. Med. 194, 669-676 (2001
172. Saxena, A., et al. Cutting edge: multiple sclerosis-like lesions induced by effector CD8 T cells recognizing a sequestered antigen on oligodendrocytes. J. Immunol. 181, 1617-1621 (2008
173. Huber, M., et al. IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis. J. Clin. Invest. 123, 247-260 (2013
174. Intlekofer, A. M., et al. Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin. Science 321, 408-411 (2008
175. Tzartos, J. S., et al. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 172, 146-155 (2008
176. Carbone, F. R., Mackay, L. K., Heath, W. R., Gebhardt, T. Distinct resident and recirculating memory T cell subsets in non-lymphoid tissues. Curr. Opin. Immunol. 25, 329-333 (2013
177. Mackay, L. K., et al. Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation. Proc. Natl Acad. Sci. USA 109, 7037-7042 (2012
178. Jiang, X., et al. Skin infection generates non-migratory memory CD8+ TRM cells providing global skin immunity. Nature 483, 227-231 (2012
179. Ariotti, S., et al. T cell memory. Skin-resident memory CD8+ T cells trigger a state of tissue-wide pathogen alert. Science 346, 101-105 (2014
180. Steinert, E. M., et al. Quantifying memory CD8 T cells reveals regionalization of immunosurveillance. Cell 161, 737-749 (2015
181. Mackay, L. K., et al. The developmental pathway for CD103+CD8+ tissue-resident memory T cells of skin. Nat. Immunol. 14, 1294-1301 (2013
182. Skon, C. N., et al. Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cells. Nat. Immunol. 14, 1285-1293 (2013
183. Masson, F., et al. Brain microenvironment promotes the final functional maturation of tumor-specific effector CD8+ T cells. J. Immunol. 179, 845-853 (2007
184. Shimamura, K., Takeichi, M. Local and transient expression of E-cadherin involved in mouse embryonic brain morphogenesis. Development 116, 1011-1019 (1992
185. Mackay, L. K., et al. Cutting edge: CD69 interference with sphingosine-1-phosphate receptor function regulates peripheral T cell retention. J. Immunol. 194, 2059-2063 (2015
186. Mackay, L. K., et al. Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes. Science 352, 459-463 (2016
187. Wakim, L. M., et al. The molecular signature of tissue resident memory CD8 T cells isolated from the brain. J. Immunol. 189, 3462-3471 (2012
188. Zhang, N., Bevan, M. J. Transforming growth factor-signaling controls the formation and maintenance of gut-resident memory T cells by regulating migration and retention. Immunity 39, 687-696 (2013
189. Mackay, L. K., et al. T-Box transcription factors combine with the cytokines TGF-and IL-15 to control tissue-resident memory T cell fate. Immunity 43, 1101-1111 (2015
190. Graham, J. B., Da Costa, A., Lund, J. M. Regulatory T cells shape the resident memory T cell response to virus infection in the tissues. J. Immunol. 192, 683-690 (2014
191. Prasad, S., Hu, S., Sheng, W. S., Singh, A., Lokensgard, J. R. Tregs modulate lymphocyte proliferation, activation, and resident-memory T-cell accumulation within the brain during MCMV infection. PLoS ONE 10, e0145457 (2015
192. Zaid, A., et al. Persistence of skin-resident memory T cells within an epidermal niche. Proc. Natl Acad. Sci. USA 111, 5307-5312 (2014
193. Schenkel, J. M., et al. T cell memory. Resident memory CD8 T cells trigger protective innate and adaptive immune responses. Science 346, 98-101 (2014).
194. Kim, J. M., Rasmussen, J. P., Rudensky, A. Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8, 191-197 (2007
195. Lowther, D. E., et al. Th1 not Th17 cells drive spontaneous MS-like disease despite a functional regulatory T cell response. Acta Neuropathol. 126, 501-515 (2013
196. Kohm, A. P., Carpentier, P. A., Anger, H. A., Miller, S. D. Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169, 4712-4716 (2002
197. McGeachy, M. J., Stephens, L. A., Anderton, S. M. Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. J. Immunol. 175, 3025-3032 (2005
198. Josefowicz, S. Z., et al. Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 482, 395-399 (2012
199. Bettelli, E., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235-238 (2006
200. Korn, T., et al. IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells. Nature 448, 484-487 (2007
201. O'Connor, R. A., Malpass, K. H., Anderton, S. M. The inflamed central nervous system drives the activation and rapid proliferation of Foxp3+ regulatory T cells. J. Immunol. 179, 958-966 (2007
202. Korn, T., et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13, 423-431 (2007
203. Li, M. O., Rudensky, A. Y. T cell receptor signalling in the control of regulatory T cell differentiation and function. Nat. Rev. Immunol. 16, 220-233 (2016
204. Vahl, J. C., et al. Continuous T cell receptor signals maintain a functional regulatory T cell pool. Immunity 41, 722-736 (2014
205. Levine, A. G., Arvey, A., Jin, W., Rudensky, A. Y. Continuous requirement for the TCR in regulatory T cell function. Nat. Immunol. 15, 1070-1078 (2014
206. Chaudhry, A., et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 34, 566-578 (2011
207. Vasanthakumar, A., et al. The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells. Nat. Immunol. 16, 276-285 (2015
208. Schiering, C., et al. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 513, 564-568 (2014
209. Rosenblum, M. D., et al. Response to self antigen imprints regulatory memory in tissues. Nature 480, 538-542 (2011
210. Matsumoto, M., et al. Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation. Immunity 41, 1040-1051 (2014
211. Shen, P., et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 507, 366-370 (2014
212. Hauser, S. L., et al. B-Cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 358, 676-688 (2008
213. Miller, A. H., Raison, C. L. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat. Rev. Immunol. 16, 22-34 (2016
214. Derecki, N. C., et al. Regulation of learning and memory by meningeal immunity: a key role for IL-4. J. Exp. Med. 207, 1067-1080 (2010
215. Filiano, A. J., et al. Unexpected role of interferon-in regulating neuronal connectivity and social behaviour. Nature 535, 425-429 (2016
216. Baruch, K., et al. Aging. Aging-induced type I interferon response at the choroid plexus negatively affects brain function. Science 346, 89-93 (2014
217. Baruch, K., et al. CNS-specific immunity at the choroid plexus shifts toward destructive Th2 inflammation in brain aging. Proc. Natl Acad. Sci. USA 110, 2264-2269 (2013
218. Choi, G. B., et al. The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science 351, 933-939 (2016
219. Selkoe, D. J., Hardy, J. The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Mol. Med. 8, 595-608 (2016
220. Griffin, W. S., et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl Acad. Sci. USA 86, 7611-7615 (1989
221. vom Berg, J., et al. Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline. Nat. Med. 18, 1812-1819 (2012
222. Monsonego, A., et al. Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease. J. Clin. Invest. 112, 415-422 (2003
223. Rogers, J., Luber-Narod, J., Styren, S. D., Civin, W. H. Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease. Neurobiol. Aging 9, 339-349 (1988
224. Togo, T., et al. Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases. J. Neuroimmunol. 124, 83-92 (2002
225. Baruch, K., et al. Breaking immune tolerance by targeting Foxp3+ regulatory T cells mitigates Alzheimer's disease pathology. Nat. Commun. 6, 7967 (2015
226. Bryson, K. J., Lynch, M. A. Linking T cells to Alzheimer's disease: from neurodegeneration to neurorepair. Curr. Opin. Pharmacol. 26, 67-73 (2016
227. Heppner, F. L., Ransohoff, R. M., Becher, B. Immune attack: the role of inflammation in Alzheimer disease. Nat. Rev. Neurosci. 16, 358-372 (2015
228. Schenk, D., et al. Immunization with amyloid-attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173-177 (1999
229. Hock, C., et al. Generation of antibodies specific for beta-amyloid by vaccination of patients with Alzheimer disease. Nat. Med. 8, 1270-1275 (2002
230. Sevigny, J., et al. The antibody aducanumab reduces A plaques in Alzheimer's disease. Nature 537, 50-56 (2016
231. Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., Coffman, R. L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2348-2357 (1986
232. Mosmann, T. R., Sad, S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17, 138-146 (1996
233. Traugott, U., Reinherz, E. L., Raine, C. S. Multiple sclerosis: distribution of T cell subsets within active chronic lesions. Science 219, 308-310 (1983
234. Traugott, U., Lebon, P. Interferon-and Ia antigen are present on astrocytes in active chronic multiple sclerosis lesions. J. Neurol. Sci. 84, 257-264 (1988
235. Chu, C. Q., Wittmer, S., Dalton, D. K. Failure to suppress the expansion of the activated CD4 T cell population in interferon-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp. Med. 192, 123-128 (2000
236. Korn, T., Bettelli, E., Oukka, M., Kuchroo, V. K. IL-17 and Th17 Cells. Annu. Rev. Immunol. 27, 485-517 (2009
237. Iwakura, Y., Ishigame, H., Saijo, S., Nakae, S. Functional specialization of interleukin-17 family members. Immunity 34, 149-162 (2011
238. Harrington, L. E., et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123-1132 (2005
239. Park, H., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133-1141 (2005
240. Ivanov, I. I., et al. The orphan nuclear receptor RORt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126, 1121-1133 (2006
241. Lee, Y., et al. Induction and molecular signature of pathogenic TH17 cells. Nat. Immunol. 13, 991-999 (2012
242. Treiner, E., et al. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature 422, 164-169 (2003
243. Treiner, E., Liblau, R. S. Mucosal-associated invariant T cells in multiple sclerosis: the jury is still out. Front. Immunol. 6, 503 (2015
244. Corbett, A. J., et al. T-Cell activation by transitory neo-antigens derived from distinct microbial pathways. Nature 509, 361-365 (2014
245. Ussher, J. E., et al. CD161++ CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner. Eur. J. Immunol. 44, 195-203 (2014
246. Willing, A., et al. CD8+ MAIT cells infiltrate into the CNS and alterations in their blood frequencies correlate with IL-18 serum levels in multiple sclerosis. Eur. J. Immunol. 44, 3119-3128 (2014
247. Held, K., et al. T-cell receptors from multiple sclerosis brain lesions show MAIT cell-related features. Neurol. Neuroimmunol. Neuroinflamm. 2, e107 (2015
248. Wilson, R. P., et al. STAT3 is a critical cell-intrinsic regulator of human unconventional T cell numbers and function. J. Exp. Med. 212, 855-864 (2015
249. Croxford, J. L., Miyake, S., Huang, Y.-Y., Shimamura, M., Yamamura, T. Invariant V19i T cells regulate autoimmune inflammation. Nat. Immunol. 7, 987-994 (2006
250. Guilliams, M., et al. Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nat. Rev. Immunol. 14, 571-578 (2014
251. Murphy, T. L., et al. Transcriptional control of dendritic cell development. Annu. Rev. Immunol. 34, 93-119 (2016
252. Quintana, E., et al. DNGR-1+ dendritic cells are located in meningeal membrane and choroid plexus of the noninjured brain. Glia 63, 2231-2248 (2015
253. Ling, E. A., Kaur, C., Lu, J. Origin, nature, and some functional considerations of intraventricular macrophages, with special reference to the epiplexus cells. Microsc. Res. Tech. 41, 43-56 (1998
254. Kivisäkk, P., et al. Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc. Natl Acad. Sci. USA 100, 8389-8394 (2003
255. Kivisäkk, P., et al. Expression of CCR7 in multiple sclerosis: implications for CNS immunity. Ann. Neurol. 55, 627-638 (2004